Life sciences news
-
argenx announces positive topline Phase 3 data from ADAPT-SC study evaluating subcutaneous efgartigimod for generalized myasthenia gravis
Tuesday March 22nd 2022
Read more
-
V-Bio Ventures’ Portfolio Company Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals
Wednesday March 16th 2022
Read more
-
Confo Therapeutics doses first subjects in Phase 1 clinical trial of CFTX-1554 for the treatment of neuropathic pain
Thursday March 10th 2022
Read more
-
flanders.healthTech launches 14 unique innovation projects in healthcare
Thursday March 10th 2022
Read more
-
MyCellHub strengthens its growth ambitions by appointing Jacques Parlongue as CEO
Tuesday March 8th 2022
Read more
-
KU Leuven’s Biosensors group develops first label-free assay characterizing COVID-19 antibodies directly in patient blood, using FOx BIOSYSTEMS platform
Tuesday March 8th 2022
Read more
-
UCB expands innovation footprint with new state-of-the-art gene therapy facility
Tuesday March 8th 2022
Read more
-
Unexpected element in aging process discovered
Friday March 4th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
V-Bio Ventures’ portfolio company Syndesi Therapeutics acquired by AbbVie to strengthen its neuroscience portfolio
Wednesday March 2nd 2022
Read more
-
The fight against cancer intensified thanks to SCK CEN and the IRE
Monday February 28th 2022
Read more
-
2.3 million grant awarded to Flen Health by the Ministry of the Economy of Luxembourg (MECO)
Monday February 28th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
